Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is…
eabramovichJanuary 8, 2021
iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225,…
eabramovichDecember 18, 2020
This year marks the 20th anniversary of the founding of Genome BC, the genomics research organization…
eabramovichDecember 17, 2020
Share prices of AbCellera Biologics Inc. (Nasdaq:ABCL) nearly tripled over the course of their first…
eabramovichDecember 16, 2020
Dr. Gail Murphy, Vice-President, Research & Innovation has announced Dr. Rachel Fernandez will be UBC’s…
eabramovichDecember 14, 2020
A Canadian biotechnology company has made history with the announcement of the BioNTech/Pfizer COVID-19 vaccine…
eabramovichDecember 11, 2020
Environmental Assessment (EA) is a critical step in evaluating the health of reclaimed mine sites.…
eabramovichDecember 10, 2020
One aspect of human existence we know to be universal is that we each have…
eabramovichDecember 9, 2020
